Stelara 130 MG/26 ML vial 26ML

Ended Awarded

Contract number
SPE2DB24FX7Q0
Awardee
Awarding agency
Obligated
$3,731

Award facts

Contract value 100% obligated
$3,730.56 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The $3,730.56 contract is for the delivery of STELARA 130 MG/26 ML VIAL 26ML, a biologic pharmaceutical product, with a completion date of April 18, 2024. This award is part of a larger $4,999,999 indefinite delivery vehicle (IDV) contract SPE2DB between DMS Pharmaceutical Group and DLA, which enables DLA to issue delivery orders for a broad range of pharmaceutical supplies to support military health facilities worldwide. The contract has no set-aside designation.

Quick answers

Who was awarded contract SPE2DB24FX7Q0?

SPE2DB24FX7Q0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on March 28, 2024.

How much is contract SPE2DB24FX7Q0 worth?

The government has obligated $3,731 on SPE2DB24FX7Q0.

Is contract SPE2DB24FX7Q0 an order under another contract?

Yes. SPE2DB24FX7Q0 is a delivery order under SPE2DB20D9354, an indefinite delivery contract.

Was contract SPE2DB24FX7Q0 competed?

The extent of competition for SPE2DB24FX7Q0 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award